SHMT2 and colorectal carcinoma: When we treated CRC cells with PLP which decreases dimeric SHMT2, β-catenin protein level was significantly reduced (data not shown), suggesting that dimeric SHMT2 might be responsible for β-catenin stabilization which is worth further study.